Pharma deal in focus in Europe
496338
After a weak start, European equity markets rallied by lunchtime on Thursday, helped by merger activity in the pharmaceuticals sector and bid speculation in the Spanish property sector.
653679
The EU market welcomes the drugmaker's copy of a treatment for anemia.
30848
The European market rules will force deals to be made one country at a time.
23358
Private equity firm The Carlyle Group  is mulling a bid for the generics business of Germany's Merck  KGaA , a unit worth at least 4 billion euros ($5.3  billion), a source close to the process said.
207285
Pfizer Inc. PFE.N has signed a deal  with Schering AG SCHG.DE granting it a worldwide license to  Schering's ADP receptor antagonist program, the U.S. drug maker  said on Wednesday.
180751
A broad portfolio of drugs helps French pharmaceutical stay ahead of its peers.
725625
German chemicals and pharmaceuticals giant Bayer says it is still open to further acquisitions even though it was still in the process of integrating Berlin-based drug maker Schering which it recently acquired for close to 17 billion euros (22 billion dollars).
440113
Pharmacopeia presents at an investors' conference.
665690
The developing biopharmaceutical company announces a share offering.
211620
The drug maker's paperwork also is part of the actions required to issue shares in connection its proposed offer Polish pharmaceutical company known as Polfa Kutno.
613574
German drug firm Schwarz Pharma is being bought in a 4.4bn euro deal, the third industry tie-up in recent days.
511170
Now might be a great time to load up on cutting-edge drugmakers.
312096
The U.K. and Ireland have taken the lead on dealmaking in the technology sector so far this year.
764344
The anti-industry crusader targets pharmaceuticals.
230439
LONDON (CBS.MW) -- European drugmakers Novartis, Schering and Sanofi-Aventis on Thursday all posted rising third-quarter sales, helped by sales lifts in the companies&#39; key products.
595644
The British drugmaker looks to regain momentum this year.
423754
Consolidation in Europe's drugs   sector gathered steam on Thursday as Germany's Merck MRCG.DE   unveiled a $13.3-billion deal to buy Europe's top biotech firm   Serono SEO.VX, and Denmark's Nycomed won the drugs unit of   Altana ALTG.DE.